TVGNW · Tevogen Inc. · Executive Compensation
Market Cap
$44.41M
Shares
6.51M
Volume · Oct 21
836.13K
Avg daily vol (3M)
405.79K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $10,421,000 |
| Kirti Desai | Chief Financial Officer | $1,230,000 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $722,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $87,764,783 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $350,000 |
| Kirti Desai | Chief Financial Officer | $300,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $2,926,000 |
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $501,000 |
| Kirti Desai | Chief Financial Officer | $300,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Victor Sordillo | Class II director | Appointed | 2026-08-26 |
| Dr. Keow Lin Goh | Class II director | Appointed | 2026-08-26 |
| Suren Ajjarapu | director | Resigned | 2024-08-23 |
| Ryan Saadi | Chairperson | Appointed | 2024-02-14 |
| Victor Sordillo | Director Nominee | Appointed | 2024-02-14 |
| Susan Podlogar | Director Nominee | Appointed | 2024-02-14 |
| Curtis Patton | Director Nominee | Appointed | 2024-02-14 |
| Keow Lin Goh | Director Nominee | Appointed | 2024-02-14 |
| Jeffrey Feike | Director Nominee | Appointed | 2024-02-14 |
| Surendra Ajjarapu | Director Nominee | Appointed | 2024-02-14 |
| Sadiq Khan | Chief Commercial Officer | Appointed | 2024-02-14 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | Appointed | 2024-02-14 |
| Kirti Desai | Chief Financial Officer | Appointed | 2024-02-14 |
| Ryan Saadi | Chief Executive Officer, Chairperson and Director Nominee | Appointed | 2024-02-14 |
| Francis Knuettel II | Chief Financial Officer | Appointed | 2023-06-07 |
| Surendra Ajjarapu | Chief Executive Officer | Appointed | 2023-06-07 |
| Surendra Ajjarapu | member of the Board | Appointed | 2023-06-07 |
| Francis Knuettel II | Chairman | Appointed | 2023-06-07 |
| Avinaesh Wadhwani | member of the Board | Appointed | 2023-06-07 |
| Donald Fell | member of the Board | Appointed | 2023-06-07 |
| Scott Sussman | member of the Board | Appointed | 2023-06-07 |
| Jeff Rogers | officer of the Company | Resigned | 2023-06-07 |
| Ben Baldanza | officer of the Company | Resigned | 2023-06-07 |
| Michael Peterson | member of the Board | Appointed | 2023-06-07 |
| Richard N. Peretz | officer of the Company | Resigned | 2023-06-07 |
Leadership
- Dr. Ryan Saadi CEO, Board Member
- Ryan Saadi CEO, Chairman
- Surendra Ajjarapu CEO, Board Member
- Francis Knuettel II Chairman, CFO
- Jeff Rogers CFO
- Kirti Desai CFO
- Avinaesh Wadhwani Board Member
- Curtis Patton Board Member
- Donald Fell Board Member
- Dr. Curtis Patton Board Member
- Dr. Keow Lin Goh Board Member
- Jeffrey Feike Board Member
- Keow Lin Goh Board Member
- Michael Peterson Board Member
- Scott Sussman Board Member
- Susan Podlogar Board Member
- Victor Sordillo Board Member